News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Novo Nordisk obesity drug results underwhelm investors

Started by riky, March 19, 2013, 08:00:14 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Novo Nordisk obesity drug results underwhelm investors

<p><a href="http://news.yahoo.com/novo-nordisk-pleased-obesity-trial-results-120322490--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/uSJAQZgCrX8bfS4uhaqq2w--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-18T120322Z_1_CBRE92H0XHP00_RTROPTP_2_USA.JPG" width="130" height="86" alt="Women sit on bench in New York" align="left" title="Women sit on bench in New York" border="0" /></a>COPENHAGEN (Reuters) - Overweight and obese diabetes patients given high doses of Novo Nordisk's drug liraglutide achieved 6 percent weight loss in a clinical trial, only slightly above the loss seen in those on a lower dose. The Danish group, the world's biggest insulin producer, said on Monday it was pleased with the results. But investors worried about where it left Novo's strategy for a premium-priced high-dose obesity treatment and shares in the company fell 4 percent. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login